Nov 4 (Reuters)-
Zeria Pharmaceutical Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Sep 30, 2016 Sep 30, 2015 Mar 31, 2017
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 32.31 30.34 66.00
(+6.5 pct) (+0.7 pct) (+5.6 pct)
Operating 3.15 2.11 4.80
(+48.9 pct) (-7.2 pct) (+5.1 pct)
Recurring 3.08 1.58 4.60
(+94.6 pct) (-29.3 pct) (+3.4 pct)
Net 2.01 1.62 3.60
(+24.1 pct) (-23.6 pct) (+2.5 pct)
EPS 37.78 yen 30.44 yen 67.78 yen
Ann Div 31.00 yen 32.00 yen
-Q2 div 16.00 yen 15.00 yen
-Q4 div 16.00 yen 16.00 yen
NOTE - Zeria Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4559.T
((Tokyo Headline News Desk +813 6441 1812))